微生物多样性与组成与宫颈癌放化疗期间患者报告的毒性相关
高毒性患者的微生物组成变化不同,且梭菌纲物种存在组成差异。
要点
- 放化疗期间肠道微生物多样性持续下降,第5周下降最明显。
- 各时间点多样性越高与患者报告的胃肠道功能越好线性相关。
- 基线多样性不能预测治疗结束时的肠道毒性,但组成可能识别高风险患者。
核心结论
- 放疗毒性增加与肠道微生物多样性下降相关,基线多样性不能预测治疗结束时的肠道毒性,但微生物组成可能识别高毒性风险患者。
研究设计与样本
- 粪便DNA经16S rRNA测序分析,采用Shannon多样性指数评估α多样性,加权UniFrac主坐标分析比较β多样性,线性判别分析效应量筛选区分样本的微生物特征。
主要发现
- 放化疗期间肠道微生物多样性持续下降,第5周下降最大。
- EPIC肠道功能评分随治疗下降,反映症状负担增加。
- 各时间点肠道微生物多样性越高与患者报告的胃肠道功能越好线性相关。
- 高毒性患者在放化疗期间微生物组成变化不同,且梭菌纲物种存在组成差异。
临床怎么用
- 放化疗期间肠道微生物多样性下降与患者报告的胃肠道毒性增加相关,可关注微生物组成以识别高毒性风险患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Patients receiving pelvic radiation for cervical cancer experience high rates of acute gastrointestinal (GI) toxicity. The association of changes in the gut microbiome with bowel toxicity from radiation is not well characterized. METHODS AND MATERIALS: Thirty-five patients undergoing definitive chemoradiation therapy (CRT) underwent longitudinal sampling (baseline and weeks 1, 3, and 5) of the gut microbiome and prospective assessment of patient-reported GI toxicity. DNA was isolated from stool obtained at rectal examination and analyzed with 16S rRNA sequencing. GI toxicity was assessed with the Expanded Prostate Cancer Index Composite instrument to evaluate frequency, urgency, and discomfort associated with bowel function. Shannon diversity index was used to characterize alpha (within sample) diversity. Weighted UniFrac principle coordinates analysis was used to compare beta (between sample) diversity between samples using permutational multivariate analysis of variance. Linear discriminant analysis effect size highlighted microbial features that best distinguish categorized patient samples. RESULTS: Gut microbiome diversity continuously decreased over the course of CRT, with the largest decrease at week 5. Expanded Prostate Cancer Index Composite bowel function scores also declined over the course of treatment, reflecting increased symptom burden. At all individual time points, higher diversity of the gut microbiome was linearly correlated with better patient-reported GI function, but baseline diversity was not predictive of eventual outcome. Patients with high toxicity demonstrated different compositional changes during CRT in addition to compositional differences in Clostridia species. CONCLUSIONS: Over time, increased radiation toxicity is associated with decreased gut microbiome diversity. Baseline diversity is not predictive of end-of-treatment bowel toxicity, but composition may identify patients at risk for developing high toxicity.
引用
- Mitra A, Grossman Biegert GW, Delgado AY, et al. Microbial Diversity and Composition Is Associated with Patient-Reported Toxicity during Chemoradiation Therapy for Cervical Cancer. Int J Radiat Oncol Biol Phys. 2020. PMID: 31987960. doi:10.1016/j.ijrobp.2019.12.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。